logo
Select company
Select metric
1.16Cash Ratio
VS
Market
70
Sector
47
Industry
32
History
33
$ 15.28Close
$ 5.3 - $ 18 52-Week Range
Ticker Information

Ticker

ATRA

Company Name

ATARA BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ATARA BIOTHERAPEUTICS INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ATRA - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 16.9M1.16$ 14.56M
3/31/2025$ 13.99M0.29$ 47.89M
12/31/2024$ 25.18M0.19$ 134.57M
9/30/2024$ 46.6M0.3$ 155.98M
6/30/2024$ 31.46M0.21$ 148.27M
3/31/2024$ 35.23M0.19$ 180.69M
12/31/2023$ 25.99M0.18$ 142.23M
9/30/2023$ 64.94M0.82$ 79.09M
6/30/2023$ 46.04M0.62$ 74.55M
3/31/2023$ 48.89M0.72$ 67.88M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ATARA BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) Cash Ratio stands at 1.74.
  • Over the past 5 years, ATARA BIOTHERAPEUTICS INC's average Cash Ratio has been 0.93.
  • The median Cash Ratio for ATARA BIOTHERAPEUTICS INC during this period was 0.96
  • ATARA BIOTHERAPEUTICS INC reached its highest Cash Ratio over the past 5 years at 2.42.
  • The lowest Cash Ratio recorded by ATARA BIOTHERAPEUTICS INC in the same timeframe 0.18

ATARA BIOTHERAPEUTICS INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
IGMS : IGM BIOSCIENCES INC 5.06STRO : SUTRO BIOPHARMA INC 0.87MGNX : MACROGENICS INC 3.35CHRS : COHERUS ONCOLOGY INC 0.82IPSC : CENTURY THERAPEUTICS INC 3.99KPTI : KARYOPHARM THERAPEUTICS INC 0.39DOMH : DOMINARI HOLDINGS INC 0.57MGX : METAGENOMI INC 0.96FBIO : FORTRESS BIOTECH INC 1.31ZYXI : ZYNEX INC 0.24

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for ATARA BIOTHERAPEUTICS INC is calculated as follows: CashnEq [ $ 62.81M ] / LiabilitesC [ $ 36.05M ]
(=) Cash Ratio [ 1.74 ]

ATRA - Cash Ratio, Last 5 years

0.18

Minimum

Dec 31, 2023

2.42

Maximum

Dec 31, 2020

0.93

Average

0.96

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63